WASATCH ADVISORS LP 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:48 pm Sale | 2024-11-14 | 13G | Nurix Therapeutics, Inc. NRIX | WASATCH ADVISORS LP | 708,377 1.100% | -2,041,368 (-74.24%) | Filing |
| 2024-02-09 1:56 pm Purchase | 2024-02-09 | 13G | Nurix Therapeutics, Inc. NRIX | WASATCH ADVISORS LP | 2,749,745 5.700% | 211,113 (+8.32%) | Filing |
| 2023-02-08 1:07 pm Purchase | 2023-02-08 | 13G | Nurix Therapeutics, Inc. NRIX | WASATCH ADVISORS LP | 2,538,632 5.400% | 2,538,632 (New Position) | Filing |